Şunu aradınız:: ada (Maltaca - İngilizce)

kull kooperazzjoni msaħħa ada a ċaħha ħ ċ
the council of ministers may also adopt the transitional measures referred to in the second subparagraph on a proposal from the commission.

il-produttività g≠ada baxxa żżejjed
productivity still too low

ada + plaċebo (iv) tcz + plaċebo (sc)
ada + placebo (iv) tcz + placebo (sc)

manifestazzjonijiet mhux immunoloġiċi ta' ada-scid jistgħu ma jirrispondux għal strimvelis.
non-immunological manifestations of ada-scid may not respond to strimvelis.

minħabba f'hekk, il-pazjenti għandhom nuqqas ta' enzima ada.
as a result, patients lack the ada enzyme.

dawk il-pazjenti li żviluppaw ada għamlu dan fl-ewwel 3 xhur ta’ esponiment.
those patients who developed ada did so within the first 3 months of exposure.

dan jaħdem billi jitpoġġa ġene ġdid fiċ-ċelluli staminali fil-mudullun sabiex ikunu jistgħu jipproduċu ada.
it works by putting a new gene into stem cells in the bone marrow so they can make ada.

nelarabine jiġi demetilizzat malajr minn adenosine deaminase (ada) għal ara- g u mbagħad fosforat fiċ- ċellula b' deoxyguanosine kinase u deoxycytidine kinase għall - prodott tal- metaboliżmu tiegħu 5 'monophoshate.
nelarabine is rapidly demethylated by adenosine deaminase (ada) to ara-g and then phosphorylated intracellularly by deoxyguanosine kinase and deoxycytidine kinase to its 5’ -monophosphate metabolite.